Dr. Christopher Piorkowski, Divisional Vice President and Chief Medical Officer of Abbott's Electrophysiology business, is the latest guest on The Top Line podcast.
A seasoned expert in the field of electrophysiology, he joins us to discuss and explain some of Abbott’s latest solutions and advancements, as well as best practices to support treatment for abnormal heart rhythms.
EnSite X, for example, is Abbott’s revolutionary 3D heart mapping software which Piorkowski describes as the company's most important product development of the past decade and compares it to the transition from a gasoline to an electric car in terms of its implications.
And it is easy to see why. EnSite X acts as an ultra-accurate GPS system that helps physicians to locate and understand the areas in a patient’s heart needing ablation. A significant update has been the incorporation of near field technology – this helps physicians to understand which of the electrical signals that they see on the catalyst is truly from the location of a catheter, as opposed to signals that come from further away in so-called far field signals.
The discussion also takes a turn towards pulsed field ablation, something which Abbott has been working with for well over a decade.
See omnystudio.com/listener for privacy information.
A cell therapy reckoning
Automation, decentralization and the future of CAR-Ts: Advancements in cell & gene therapy manufacturing (Part III)
[Sponsored] Opportunities & Challenges of Digital Pathology Adoption in CDx Development
[Sponsored] Unlocking health equity: The promise of digital health technologies
Advancements in cell & gene therapy manufacturing (Part II)
Fulfilling the promise of cell & gene therapies through manufacturing (Part I)
A closer look at 2023's top biopharma deals and what lies ahead
A look at pharma revenue rankings
Winning formulas for the best biotech and drug names
[Sponsored] What does the future of specialist distribution look like?
Deep dive: Biopharma layoffs in Q1
The unrecognized threat of PAD
The top money raisers in biotech
A closer look at European biotech investment in 2024
Inclusivity in psoriasis trials with Takeda
Fierce Medtech's Fierce 15
[Sponsored] A Person-Centered Approach to Achieving Long-Term Success
CAR-T boxed warnings: What comes next?
Breaking down Eli Lilly’s ESG formula
Gene editing's next act
Create your
podcast in
minutes
It is Free
Pharmacy Podcast Network
Børsen Morgenbriefing
Sarah Westall - Business Game Changers
Startitup podcasty
Wall Street Breakfast